Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 2769804, 7 pages
http://dx.doi.org/10.1155/2016/2769804
Research Article

Epistatic Interaction of CYP1A1 and COMT Polymorphisms in Cervical Cancer

1Genetics Laboratory and Environmental Health Institute, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal
2Instituto de Investigação Científica Bento da Rocha Cabral, 1250-047 Lisbon, Portugal
3Dermatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1250-047 Lisbon, Portugal
4Clinical and Translational Oncology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1250-047 Lisbon, Portugal
5Molecular Oncology Group, Portuguese Institute of Oncology Porto Centre, 4200-072 Porto, Portugal

Received 24 May 2015; Revised 30 September 2015; Accepted 1 October 2015

Academic Editor: Valentina Pallottini

Copyright © 2016 Andreia Matos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Crow, “HPV: the global burden,” Nature, vol. 488, no. 7413, pp. S2–S3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. A. Moody and L. A. Laimins, “Human papillomavirus oncoproteins: pathways to transformation,” Nature Reviews Cancer, vol. 10, no. 8, pp. 550–560, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Muñoz, X. Castellsagué, A. B. de González, and L. Gissman, “Chapter 1: HPV in the etiology of human cancer,” Vaccine, vol. 24, supplement 3, pp. S1–S10, 2006. View at Publisher · View at Google Scholar
  5. E. J. Crosbie, M. H. Einstein, S. Franceschi, and H. C. Kitchener, “Human papillomavirus and cervical cancer,” The Lancet, vol. 382, no. 9895, pp. 889–899, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. E. M. Burd, “Human papillomavirus and cervical cancer,” Clinical Microbiology Reviews, vol. 16, no. 1, pp. 1–17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. S.-H. Chung, S. Franceschi, and P. F. Lambert, “Estrogen and ERalpha: culprits in cervical cancer?” Trends in Endocrinology and Metabolism, vol. 21, no. 8, pp. 504–511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Bolton and G. R. J. Thatcher, “Potential mechanisms of estrogen quinone carcinogenesis,” Chemical Research in Toxicology, vol. 21, no. 1, pp. 93–101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. E. P. Khvostova, V. O. Pustylnyak, and L. F. Gulyaeva, “Genetic polymorphism of estrogen metabolizing enzymes in siberian women with breast cancer,” Genetic Testing and Molecular Biomarkers, vol. 16, no. 3, pp. 167–173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Yager, “Endogenous estrogens as carcinogens through metabolic activation,” Journal of the National Cancer Institute. Monographs, no. 27, pp. 67–73, 2000. View at Google Scholar
  11. E. L. Cavalieri, D. E. Stack, P. D. Devanesan et al., “Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 20, pp. 10937–10942, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Sasaki, M. Kaneuchi, S. Fujimoto, Y. Tanaka, and R. Dahiya, “CYP1B1 gene in endometrial cancer,” Molecular and Cellular Endocrinology, vol. 202, no. 1-2, pp. 171–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. O. C. Martínez-Ramírez, R. Pérez-Morales, C. Castro et al., “Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women,” Breast, vol. 22, no. 3, pp. 335–343, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Tsuchiya, M. Nakajima, and T. Yokoi, “Cytochrome P450-mediated metabolism of estrogens and its regulation in human,” Cancer Letters, vol. 227, no. 2, pp. 115–124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. J. Kim, S. J. Um, T. Y. Kim et al., “Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells,” International Journal of Gynecological Cancer, vol. 10, no. 2, pp. 157–164, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Moodley, J. Moodley, R. Chetty, and C. S. Herrington, “The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review,” International Journal of Gynecological Cancer, vol. 13, no. 2, pp. 103–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Paraskevaidis, N. Drakoulis, I. Roots, C. E. Orfanos, and C. C. Zouboulis, “Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne,” Dermatology, vol. 196, no. 1, pp. 171–175, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. S. V. Vadlamuri, D. D. Glover, T. Turner, and M. A. Sarkar, “Regiospecific expression of cytochrome P4501A1 and 1B1 in human uterine tissue,” Cancer Letters, vol. 122, no. 1-2, pp. 143–150, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. E. de Oliveira, R. de Aquino Castro, M. T. V. Gomes et al., “The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids,” Maturitas, vol. 60, no. 3-4, pp. 235–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. M. Gooden, J. C. Schroeder, K. E. North et al., “Val153Met polymorphism of catechol-O-methyltransferase and prevalence of uterine leiomyomata,” Reproductive Sciences, vol. 14, no. 2, pp. 117–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Hirata, Y. Hinoda, N. Okayama et al., “COMT polymorphisms affecting protein expression are risk factors for endometrial cancer,” Molecular Carcinogenesis, vol. 47, no. 10, pp. 768–774, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. D. K. Lahiri and J. I. Numberger, “A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies,” Nucleic Acids Research, vol. 19, no. 19, article 5444, 1991. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Doherty, N. S. Weiss, R. J. Freeman et al., “Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 2, pp. 357–366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. O. Mueck and H. Seeger, “2-methoxyestradiol—biology and mechanism of action,” Steroids, vol. 75, no. 10, pp. 625–631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. E. Theron, E. M. Nolte, L. Lafanechère, and A. M. Joubert, “Molecular crosstalk between apoptosis and autophagy induced by a novel 2-methoxyestradiol analogue in cervical adenocarcinoma cells,” Cancer Cell International, vol. 13, no. 1, article 87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. M. Abdolmaleky, K.-H. Cheng, S. V. Faraone et al., “Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder,” Human Molecular Genetics, vol. 15, no. 21, pp. 3132–3145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Dawling, N. Roodi, and F. F. Parl, “Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1,” Cancer Research, vol. 63, no. 12, pp. 3127–3132, 2003. View at Google Scholar · View at Scopus
  28. R.-E. Go, K.-A. Hwang, and K.-C. Choi, “Cytochrome P450 1 family and cancers,” Journal of Steroid Biochemistry and Molecular Biology, vol. 147, pp. 24–30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. N. T. Nguyen, T. Nakahama, D. H. Le, L. Van Son, H. H. Chu, and T. Kishimoto, “Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research,” Frontiers in Immunology, vol. 5, article 551, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Worda, M. O. Sator, C. Schneeberger, T. Jantschev, K. Ferlitsch, and J. C. Huber, “Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women,” Human Reproduction, vol. 18, no. 2, pp. 262–266, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Cutolo, A. Sulli, S. Capellino et al., “Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity,” Lupus, vol. 13, no. 9, pp. 635–638, 2004. View at Publisher · View at Google Scholar · View at Scopus